Multiple dose study of brilacidin [PMX 30063] in male and female volunteers in the USA
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2017
At a glance
- Drugs Brilacidin (Primary)
- Indications Skin and soft tissue infections; Staphylococcal infections
- Focus Adverse reactions; Pharmacokinetics
- 05 Jun 2017 Preliminary results presented at the ASM Microbe 2017
- 23 Oct 2011 Further results presented at the 49th Annual Meeting of the Infectious Diseases Society of America.
- 20 Sep 2011 Results presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy.